GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

GE HealthCare is expanding its AI partnership with Nvidia to include autonomous X-ray and ultrasound applications.

At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

GE Healthcare and Nvidia have launched a collaboration to develop AI-powered autonomous X-ray and ultrasound technologies, with an aim to address growing radiology staff shortages and improve ...

GE HealthCare has introduced the latest Invenia ABUS Premium to expedite scanning while driving early detection of cancer in dense breasts.

and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE ...

Probo Medical ("Probo"), a global diagnostic imaging solutions provider, has announced its new distribution relationship with GE HealthCare. This relationship signifies a major milestone for Probo and ...

GE HealthCare completes acquisition of leading radiopharmaceutical company, Nihon Medi-Physics in Japan: Chicago Tuesday, April 1, 2025, 12:00 Hrs [IST] GE HealthCare Technologies ...

Today, GE HealthCare announced the commercial launch of Flyrcado, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent, now available in select U ...